Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
Helena Abreu do ValleParamdeep KaurJanice S KwonRona CheifetzLesa DawsonGillian E HanleyPublished in: Journal of gynecologic oncology (2022)
mutations had higher risk of osteoporosis after RRBSO, but were not at increased risk of fractures during our follow-up. Low rates of DEXA-scan and bisphosphonates use indicate we can improve prevention of bone loss.